|
FOR IMMEDIATE RELEASE
SAN DIEGO (January 18, 2012) - TriLink BioTechnologies Inc. (TriLink) announced that it has entered into a distribution agreement with Sigma-Aldrich to sell its CleanAmp™ dNTPs globally.
As an innovative approach to Hot Start PCR, TriLink's CleanAmp™ dNTPs are an ideal complement to Sigma-Aldrich's product and service offerings. In developing CleanAmp™, TriLink applied their expertise in modified nucleic acid chemistry to resolve common PCR problems, such as primer dimer formation and mis-priming. The latest advancement in CleanAmp™ dNTP chemistry allows improved amplicon yield in endpoint PCR and earlier Cq values in fast cycling real-time PCR.
"TriLink is very pleased to have its innovative Hot Start PCR technology, CleanAmp™ dNTPs added to the line of PCR reagents offered by Sigma. CleanAmp™ dNTPs are a great addition to Sigma's portfolio and Sigma's global distribution channels will undoubtedly get this novel technology into more hands," stated TriLink's President and CEO, Richard Hogrefe, Ph.D.
# # #
About TriLink
TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the research, diagnostic and OEM markets. In addition, custom chemistry, long RNA transcript synthesis and contract research services in ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 85 scientists and other professionals. For more information about the firm and products, call 858-546-0004, email info@trilinkbiotech.com, or visit their web site at www.trilinkbiotech.com.